AFB1‐induced mutagenesis of the gpt gene in AS52 cells

Aflatoxin B1 (AFB1) is a potent mutagen and an important risk factor for hepatocellular carcinoma (HCC) in humans. Transgenic mouse strains and cells in culture have been used to detect different types of mutations caused by AFB1 and investigate the molecular determinants of their location and frequency. The AFB1 mutational spectrum in the gpt gene was markedly different in AS52 cells compared with the liver in gpt delta B6C3F1 transgenic mice. The results demonstrate the importance of metabolism, chromosomal location, transcription and selection conditions on mutational spectra. Environ. Mol. Mutagen. 2012. © 2012 Wiley Periodicals, Inc.

[1]  J. Essigmann,et al.  Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  N. Mei,et al.  Differential mutagenicity of aflatoxin B1 in the liver of neonatal and adult mice , 2009, Environmental and molecular mutagenesis.

[3]  C. Wild,et al.  Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. , 2008, Annual Review of Public Health.

[4]  T. Kunkel,et al.  The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases , 2008, Cell Research.

[5]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[6]  A. Koren.  The role of the DNA damage checkpoint in regulation of translesion DNA synthesis. , 2007, Mutagenesis.

[7]  Sequence specificity , 2005, Nature Genetics.

[8]  G. Douglas,et al.  Treatment and sampling protocols for transgenic mutation assays , 2003, Environmental and molecular mutagenesis.

[9]  C. Wild,et al.  Validation of exposure and risk biomarkers: aflatoxin as a case study , 2002 .

[10]  C. Sengstag,et al.  Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line , 2001, Molecular carcinogenesis.

[11]  J. Essigmann,et al.  The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. , 2001, Carcinogenesis.

[12]  M. Yamada,et al.  Characterization of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the colon of gpt delta transgenic mouse: novel G:C deletions beside runs of identical bases. , 2000, Carcinogenesis.

[13]  O. Ueda,et al.  Mutagenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the new gpt delta transgenic mouse. , 1999, Cancer letters.

[14]  D. Jerina,et al.  Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene. , 1999, Carcinogenesis.

[15]  K. Anderson,et al.  Co-mutagenicity of coumarin (1,2-benzopyrone) with aflatoxin B1 and human liver S9 in mammalian cells. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  O. Ueda,et al.  Spectra of gpt mutations in ethylnitrosourea‐treated and untreated transgenic mice , 1999, Environmental and molecular mutagenesis.

[17]  P. Upton,et al.  Detection of cyclophosphamide‐induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice , 1999, Environmental and molecular mutagenesis.

[18]  L. Ferguson,et al.  Amsacrine‐induced mutations in AS52 cells , 1998, Environmental and molecular mutagenesis.

[19]  K. Anderson,et al.  Coumarin chemoprotection against aflatoxin B1‐induced gene mutation in a mammalian cell system: A species difference in mutagen activation and protection with chick embryo and rat liver S9 , 1998, Environmental and molecular mutagenesis.

[20]  C. Kolar,et al.  Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) when activated by hamster pancreatic duct epithelial cells: a chemopreventive role for glutathione. , 1997, Mutation research.

[21]  W. Thilly,et al.  Mutational spectra vary with exposure conditions: benzo[a]pyrene in human cells. , 1996, Mutation research.

[22]  T. Skopek,et al.  Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. , 1996, Cancer research.

[23]  J. Essigmann,et al.  Mutational properties of the primary aflatoxin B1-DNA adduct. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Skopek,et al.  System Issues: Mutagenic response of the endogenous hprt gene and lacl transgene in benzo[a]pyrene‐treated Big Blue™ B6C3F1 mice , 1996 .

[25]  T. Skopek,et al.  Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice. , 1996, Environmental and molecular mutagenesis.

[26]  O. Ueda,et al.  Other transgenic mutation assays: A new transgenic mouse mutagenesis test system using Spi− and 6‐thioguanine selections , 1996, Environmental and molecular mutagenesis.

[27]  W. T. Adams,et al.  Computer program for the analysis of mutational spectra: application to p53 mutations. , 1994, Carcinogenesis.

[28]  J. Groopman,et al.  Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. , 1992, Cancer research.

[29]  K. Tindall,et al.  Molecular analysis of spontaneous mutations at the gpt locus in Chinese hamster ovary (AS52) cells. , 1989, Mutation research.

[30]  P. Hanawalt.  Preferential repair of damage in actively transcribed DNA sequences in vivo. , 1989, Genome.

[31]  M. Whitlow,et al.  Mapping the binding site of aflatoxin B1 in DNA: systematic analysis of the reactivity of aflatoxin B1 with guanines in different DNA sequences. , 1988, Biochemistry.

[32]  P C Hanawalt,et al.  Heterogeneous DNA damage and repair in the mammalian genome. , 1987, Cancer research.

[33]  R. Davidson,et al.  Sequence analysis of spontaneous mutations in a shuttle vector gene integrated into mammalian chromosomal DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Adams Wt,et al.  Statistical test for the comparison of samples from mutational spectra , 1987 .

[35]  T R Skopek,et al.  Statistical test for the comparison of samples from mutational spectra. , 1987, Journal of molecular biology.

[36]  K. Tindall,et al.  Quantitative and molecular analyses of ethyl methanesulfonate- and ICR 191-induced mutation in AS52 cells. , 1986, Mutation research.

[37]  K. Tindall,et al.  Analyses of mutation in pSV2gpt-transformed CHO cells. , 1986, Mutation research.

[38]  K. Tindall,et al.  Detection of deletion mutations in pSV2gpt-transformed cells , 1984, Molecular and cellular biology.

[39]  P. Hanawalt,et al.  Restricted repair of aflatoxin B1 Induced damage In α DNA of monkey cells , 1983 .

[40]  J. Miller,et al.  Base substitution mutations induced by metabolically activated aflatoxin B1. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Hanawalt,et al.  Restricted repair of aflatoxin B1 induced damage in alpha DNA of monkey cells. , 1983, Nucleic acids research.

[42]  M. Z. Humayun,et al.  Sequence specificity in aflatoxin B1--DNA interactions. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Mulligan,et al.  Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Thilly,et al.  Phenotypic lag and mutation to 6-thioguanine resistance in diploid human lymphoblasts. , 1978, Mutation research.